Charmacy Pharmaceutical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	4,385	4,385	4,348	4,141	3,763
Other Revenue	-	50.34	56.11	34.61	30.55
Revenue	4,385	4,435	4,404	4,175	3,794
Revenue Growth (YoY)	-1.15%	0.72%	5.47%	10.06%	-4.96%
Cost of Revenue	4,045	4,115	4,115	3,907	3,560
Gross Profit	339.88	320.88	288.38	268.61	234.12
Selling, General & Admin	181.37	175.27	170	162.57	151.85
Other Operating Expenses	9.44	10.33	9.3	10.07	8.13
Operating Expenses	206.77	185.67	180.11	175.12	159.69
Operating Income	133.11	135.21	108.28	93.49	74.42
Interest Expense	-56.83	-62.46	-41.93	-35.07	-41.52
Interest & Investment Income	2.2	3.98	4.3	4.6	3.8
Currency Exchange Gain (Loss)	-	-0.26	-0.36	-0.75	0.14
Other Non Operating Income (Expenses)	-10.12	-3.6	-4.11	-6.99	-4.01
EBT Excluding Unusual Items	68.36	72.87	66.17	55.28	32.83
Impairment of Goodwill	-	-0.03	-	-	-
Gain (Loss) on Sale of Investments	-	-	-0.1	-	-
Gain (Loss) on Sale of Assets	-0.18	0.31	0.05	65.84	0.15
Asset Writedown	-3.87	-0.33	-0.01	-	-0.01
Other Unusual Items	-	-1.62	1.32	0.94	0.01
Pretax Income	64.31	71.19	67.42	122.05	32.98
Income Tax Expense	18.04	17.91	16.07	31.58	9.83
Earnings From Continuing Operations	46.27	53.28	51.34	90.47	23.15
Net Income	46.27	53.28	51.34	90.47	23.15
Net Income to Common	46.27	53.28	51.34	90.47	23.15
Net Income Growth	-13.16%	3.78%	-43.25%	290.76%	-42.91%
Shares Outstanding (Basic)	108	108	108	108	108
Shares Outstanding (Diluted)	108	108	108	108	108
Shares Change (YoY)	-0.01%	-0.01%	0.00%	0.01%	-0.01%
EPS (Basic)	0.43	0.49	0.48	0.84	0.21
EPS (Diluted)	0.43	0.49	0.48	0.84	0.21
EPS Growth	-13.15%	3.79%	-43.25%	290.72%	-42.90%
Free Cash Flow	-	90.31	-137.39	35.46	-44.58
Free Cash Flow Per Share	-	0.84	-1.27	0.33	-0.41
Dividend Per Share	-	0.450	0.300	0.450	-
Dividend Growth	-	50.00%	-33.33%	-	-
Gross Margin	7.75%	7.23%	6.55%	6.43%	6.17%
Operating Margin	3.04%	3.05%	2.46%	2.24%	1.96%
Profit Margin	1.05%	1.20%	1.17%	2.17%	0.61%
Free Cash Flow Margin	-	2.04%	-3.12%	0.85%	-1.18%
EBITDA	153.61	155.71	129.95	121.03	103.52
EBITDA Margin	3.50%	3.51%	2.95%	2.90%	2.73%
D&A For EBITDA	20.5	20.5	21.68	27.54	29.09
EBIT	133.11	135.21	108.28	93.49	74.42
EBIT Margin	3.04%	3.05%	2.46%	2.24%	1.96%
Effective Tax Rate	28.05%	25.16%	23.84%	25.87%	29.80%
Revenue as Reported	4,385	4,435	4,404	4,175	3,794
Advertising Expenses	-	6.08	11.52	8.89	9.22

Source: S&P Global Market Intelligence. Standard template. Financial Sources.